Fig. 2.
Fig. 2. Tacrolimus results in long-term multilineage engraftment at the expense of donor T-cell reconstitution. / Mice conditioned with (A) 200 cGy or (B) 100 cGy from Table 4 were phenotyped at 3.5 months after BMT for donor-host origin of CD4+ and CD8+ T cells, CD19+ B cells and MAC-1+ myeloid cells. On the y-axis are shown the host and donor proportions of each of the lineages. The solid part of the bar indicates the proportion of each lineage that is of host origin; the striped part of the bar indicates the proportion of each lineage that is of donor origin. Irrelevant hIgG-treated mice had no detectable donor chimerism and thus are composed entirely of host-type cells. * Indicates P < .05 compared with donor proportion in mice receiving anti-CD40L mAb as a single agent.

Tacrolimus results in long-term multilineage engraftment at the expense of donor T-cell reconstitution.

Mice conditioned with (A) 200 cGy or (B) 100 cGy from Table 4 were phenotyped at 3.5 months after BMT for donor-host origin of CD4+ and CD8+ T cells, CD19+ B cells and MAC-1+ myeloid cells. On the y-axis are shown the host and donor proportions of each of the lineages. The solid part of the bar indicates the proportion of each lineage that is of host origin; the striped part of the bar indicates the proportion of each lineage that is of donor origin. Irrelevant hIgG-treated mice had no detectable donor chimerism and thus are composed entirely of host-type cells. * Indicates P < .05 compared with donor proportion in mice receiving anti-CD40L mAb as a single agent.

Close Modal

or Create an Account

Close Modal
Close Modal